Charged Alpha / Investment Desk
Enovix · Q3 2026 · Research packet

Growth has a price.
Funding has a cost.

Improving commercial evidence, differentiated cells; accepted-output scale and capital productivity unproven.

Dated common close
$1.60
Nov 13, 2026 · 4:00 p.m. ET
Ex-warrant common
Base present fair value
$0.21
Per share · model estimate
Weighted present value
$0.43
Subjective scenario weights
Base valuation gap
-87.1%
Base value / dated quote − 1
AVOID at $1.60

Neither base owner economics nor the subjective weighted outcome compensates for funding risk at the dated quote; bullish outcome is possible but requires much more than the current guide. Not a short-sale recommendation.

VERY HIGH: substantial funding, dilution, qualification, customer concentration and terminal dependence.

What drives the estimate

Separate product ramps and financing outcomes; current earnings are not a normalized base. FCFE makes coupon, maturity and new-share ownership visible. Simple P/E meaningless while loss-making; revenue multiple omits funding and fixed costs; no forced method blend.

Present value per share
Bear$0.00Base$0.21Bull$1.63

Case probabilities are subjective and are not statistically calibrated. Values are not price targets.

Scenario detail
CaseWeightPresent valueTerminal share
Bear30.0%$0.00—
Base50.0%$0.2173.9%
Bull20.0%$1.6368.9%

Terminal share is a fraction of present value; the bear case is a failure recovery and has no terminal value.

Forecast and financing

scenario FCFE discounted to existing common, explicit funding and dilution. The full dated ledgers show when funding and share issuance enter the calculation. Forecasts are assumptions, not company guidance.

Bear case · forecast and financing

USD millions / million shares. The 2026 annual anchor is omitted; the November 14–December 31 cash stub appears in the dated ledger. The bear 2028 annual assumption row is omitted because the case stops at the May 1 failure; the dated ledger retains period-to-failure detail.

YearRevenueGross profitOperating expensesFCFEEnding cashEnding shares
202760.0017.78138.00-157.54220.40225.39
Full dated funding and share ledger
DateRevenueFCFE before principalDebt paidGross equityFeesEnding cashSharesIssue priceConditional after failure
2026-11-301.77-7.100.000.000.00390.91225.39—False
2026-12-313.24-12.960.000.000.00377.95225.39—False
2027-01-315.10-12.250.000.000.00365.70225.39—False
2027-02-284.60-11.090.000.000.00354.61225.39—False
2027-03-315.10-12.300.000.000.00342.31225.39—False
2027-04-304.93-11.930.000.000.00330.38225.39—False
2027-05-315.10-12.350.000.000.00318.03225.39—False
2027-06-304.93-11.9811.800.000.00294.25225.39—False
2027-07-315.10-12.380.000.000.00281.87225.39—False
2027-08-315.10-12.400.000.000.00269.47225.39—False
2027-09-304.93-12.030.000.000.00257.44225.39—False
2027-10-315.10-12.450.000.000.00244.99225.39—False
2027-11-304.93-12.080.000.000.00232.91225.39—False
2027-12-315.10-12.510.000.000.00220.40225.39—False
2028-01-316.18-11.890.000.000.00208.51225.39—False
2028-02-295.78-11.140.000.000.00197.37225.39—False
2028-03-316.18-11.940.000.000.00185.43225.39—False
2028-04-285.58-10.800.000.000.00174.63225.39—False
2028-04-300.40-0.770.000.000.00173.86225.39—False
2028-05-010.20-0.390.000.000.00173.47225.39—True
Capital and terminal bridge
{
  "equity_bridge": {
    "opening_cash_estimate": 398.00654945054936,
    "net_debt_subtracted_again": false,
    "initial_shares": 225.38901900000002,
    "final_shares": 225.38901900000002,
    "cumulative_equity_raise": 0,
    "warrant_cash": 0,
    "failure_recovery": {
      "unpaid_maturity": 172.5,
      "date": "2028-05-01",
      "unfunded_net_gap": 39.028679836949124,
      "recovery_assets": 235.34230509455773,
      "remaining_debt": 404.5,
      "lease_claim": 9.16,
      "wind_down_cost": 25,
      "common_recovery": 0,
      "pp_and_e_recovery_rate": 0.3,
      "working_capital_recovery_rate": 0.5
    }
  },
  "terminal_or_finite_life": {
    "growth": 0.025,
    "ROIC": 0.16,
    "terminal_equity_value_before_minority_bound": 0,
    "terminal_pv_per_share": 0,
    "terminal_fraction": null,
    "terminal_FCFE": 0,
    "terminal_reinvestment": 0
  }
}
Base case · forecast and financing

USD millions / million shares. The 2026 annual anchor is omitted; the November 14–December 31 cash stub appears in the dated ledger. The bear 2028 annual assumption row is omitted because the case stops at the May 1 failure; the dated ledger retains period-to-failure detail.

YearRevenueGross profitOperating expensesFCFEEnding cashEnding shares
202775.0022.02140.00-157.86220.09225.39
2028115.0034.10125.00-300.5840.00350.90
2029175.0054.00110.00-95.2240.00450.09
2030255.0083.20112.00-301.1940.00763.83
2031350.00121.60120.00-35.2040.00800.49
2032460.00165.35130.00-13.4440.00814.49
2033570.00209.75140.0012.3640.00814.49
2034670.00250.40150.0038.0540.00814.49
2035750.00284.20158.0062.8040.00814.49
2036810.00307.65165.0080.5440.00814.49
Full dated funding and share ledger
DateRevenueFCFE before principalDebt paidGross equityFeesEnding cashSharesIssue priceConditional after failure
2026-11-301.77-7.100.000.000.00390.91225.39—False
2026-12-313.24-12.960.000.000.00377.95225.39—False
2027-01-316.37-12.280.000.000.00365.67225.39—False
2027-02-285.75-11.110.000.000.00354.56225.39—False
2027-03-316.37-12.330.000.000.00342.23225.39—False
2027-04-306.16-11.950.000.000.00330.28225.39—False
2027-05-316.37-12.380.000.000.00317.90225.39—False
2027-06-306.16-12.0011.800.000.00294.09225.39—False
2027-07-316.37-12.400.000.000.00281.69225.39—False
2027-08-316.37-12.430.000.000.00269.26225.39—False
2027-09-306.16-12.050.000.000.00257.21225.39—False
2027-10-316.37-12.480.000.000.00244.73225.39—False
2027-11-306.16-12.100.000.000.00232.62225.39—False
2027-12-316.37-12.530.000.000.00220.09225.39—False
2028-01-319.74-10.870.000.000.00209.21225.39—False
2028-02-299.11-10.190.000.000.00199.02225.39—False
2028-03-319.74-10.920.000.000.00188.10225.39—False
2028-04-288.80-9.880.000.000.00178.22225.39—False
2028-04-300.63-0.710.000.000.00177.51225.39—False
2028-05-010.31-0.35172.5036.821.4740.00262.211.00False
2028-05-319.43-10.470.0010.910.4440.00273.111.00False
2028-06-309.43-10.470.0010.910.4440.00284.021.00False
2028-07-319.74-10.820.0011.270.4540.00295.291.00False
2028-08-319.74-10.820.0011.270.4540.00306.551.00False
2028-09-309.43-10.470.0010.910.4440.00317.461.00False
2028-10-319.74-10.820.0011.270.4540.00328.731.00False
2028-11-309.43-10.470.0010.910.4440.00339.631.00False
2028-12-319.74-10.820.0011.270.4540.00350.901.00False
2029-01-3114.86-8.090.008.420.3440.00359.331.00False
2029-02-2813.42-7.300.007.610.3040.00366.931.00False
2029-03-3114.86-8.090.008.420.3440.00375.361.00False
2029-04-3014.38-7.830.008.150.3340.00383.511.00False
2029-05-3114.86-8.090.008.420.3440.00391.941.00False
2029-06-3014.38-7.830.008.150.3340.00400.091.00False
2029-07-3114.86-8.090.008.420.3440.00408.511.00False
2029-08-3114.86-8.090.008.420.3440.00416.941.00False
2029-09-3014.38-7.830.008.150.3340.00425.091.00False
2029-10-3114.86-8.090.008.420.3440.00433.511.00False
2029-11-3014.38-7.830.008.150.3340.00441.671.00False
2029-12-3114.86-8.090.008.420.3440.00450.091.00False
2030-01-3121.66-6.150.006.410.2640.00456.501.00False
2030-02-2819.56-5.560.005.790.2340.00462.281.00False
2030-03-3121.66-6.150.006.410.2640.00468.691.00False
2030-04-3020.96-5.950.006.200.2540.00474.891.00False
2030-05-3121.66-6.150.006.410.2640.00481.301.00False
2030-06-3020.96-5.950.006.200.2540.00487.501.00False
2030-07-3121.66-6.150.006.410.2640.00493.901.00False
2030-08-3121.66-6.150.006.410.2640.00500.311.00False
2030-09-1510.48-2.98232.00244.779.7940.00745.081.00False
2030-09-3010.48-2.520.002.630.1140.00747.711.00False
2030-10-3121.66-5.210.005.430.2240.00753.141.00False
2030-11-3020.96-5.050.005.260.2140.00758.401.00False
2030-12-3121.66-5.210.005.430.2240.00763.831.00False
2031-12-31350.00-35.200.0036.671.4740.00800.491.00False
2032-12-31460.00-13.440.0014.000.5640.00814.491.00False
2033-12-31570.0012.360.000.000.0040.00814.49—False
2034-12-31670.0038.050.000.000.0040.00814.49—False
2035-12-31750.0062.800.000.000.0040.00814.49—False
2036-12-31810.0080.540.000.000.0040.00814.49—False
Capital and terminal bridge
{
  "equity_bridge": {
    "opening_cash_estimate": 398.00654945054936,
    "net_debt_subtracted_again": false,
    "initial_shares": 225.38901900000002,
    "final_shares": 814.4923438799775,
    "cumulative_equity_raise": 589.1033248799775,
    "warrant_cash": 0,
    "failure_recovery": null
  },
  "terminal_or_finite_life": {
    "growth": 0.025,
    "ROIC": 0.16,
    "terminal_equity_value_before_minority_bound": 638.1204876077585,
    "terminal_pv_per_share": 0.1529214692294191,
    "terminal_fraction": 0.7385161542378379,
    "terminal_FCFE": 92.52747070312499,
    "terminal_reinvestment": 17.134716796874997
  }
}
Bull case · forecast and financing

USD millions / million shares. The 2026 annual anchor is omitted; the November 14–December 31 cash stub appears in the dated ledger. The bear 2028 annual assumption row is omitted because the case stops at the May 1 failure; the dated ledger retains period-to-failure detail.

YearRevenueGross profitOperating expensesFCFEEnding cashEnding shares
202785.0026.40142.00-159.35218.60225.39
2028170.0054.50150.00-318.3583.25286.39
2029350.00109.70170.00-150.9240.00323.77
2030670.00215.70205.00-359.2740.00448.52
20311,060.00370.00250.00-66.6540.00471.66
20321,500.00552.00300.0017.3540.00471.66
20331,920.00725.10350.00117.8840.00471.66
20342,260.00863.25395.00211.5440.00471.66
20352,570.00979.60435.00294.6040.00471.66
20362,800.001,066.00470.00370.9540.00471.66
Full dated funding and share ledger
DateRevenueFCFE before principalDebt paidGross equityFeesEnding cashSharesIssue priceConditional after failure
2026-11-301.77-7.100.000.000.00390.91225.39—False
2026-12-313.24-12.960.000.000.00377.95225.39—False
2027-01-317.22-12.400.000.000.00365.54225.39—False
2027-02-286.52-11.230.000.000.00354.32225.39—False
2027-03-317.22-12.450.000.000.00341.87225.39—False
2027-04-306.99-12.080.000.000.00329.79225.39—False
2027-05-317.22-12.500.000.000.00317.29225.39—False
2027-06-306.99-12.1311.800.000.00293.36225.39—False
2027-07-317.22-12.530.000.000.00280.83225.39—False
2027-08-317.22-12.560.000.000.00268.28225.39—False
2027-09-306.99-12.180.000.000.00256.10225.39—False
2027-10-317.22-12.610.000.000.00243.49225.39—False
2027-11-306.99-12.230.000.000.00231.26225.39—False
2027-12-317.22-12.660.000.000.00218.60225.39—False
2028-01-3114.40-12.520.000.000.00206.08225.39—False
2028-02-2913.47-11.740.000.000.00194.34225.39—False
2028-03-3114.40-12.570.000.000.00181.77225.39—False
2028-04-2813.01-11.380.000.000.00353.39286.39—False
2028-04-300.93-0.790.000.000.00352.60286.39—False
2028-05-010.46-0.39172.500.000.00179.71286.39—False
2028-05-3113.93-11.770.000.000.00167.93286.39—False
2028-06-3013.93-11.800.000.000.00156.14286.39—False
2028-07-3114.40-12.220.000.000.00143.92286.39—False
2028-08-3114.40-12.240.000.000.00131.68286.39—False
2028-09-3013.93-11.870.000.000.00119.81286.39—False
2028-10-3114.40-12.290.000.000.00107.52286.39—False
2028-11-3013.93-11.920.000.000.0095.60286.39—False
2028-12-3114.40-12.340.000.000.0083.25286.39—False
2029-01-3129.73-12.740.000.000.0070.51286.39—False
2029-02-2826.85-11.530.000.000.0058.98286.39—False
2029-03-3129.73-12.790.000.000.0046.18286.39—False
2029-04-3028.77-12.410.006.490.2640.00288.553.00False
2029-05-3129.73-12.830.0013.370.5340.00293.013.00False
2029-06-3028.77-12.420.0012.940.5240.00297.323.00False
2029-07-3129.73-12.830.0013.370.5340.00301.783.00False
2029-08-3129.73-12.830.0013.370.5340.00306.233.00False
2029-09-3028.77-12.420.0012.940.5240.00310.553.00False
2029-10-3129.73-12.830.0013.370.5340.00315.003.00False
2029-11-3028.77-12.420.0012.940.5240.00319.323.00False
2029-12-3129.73-12.830.0013.370.5340.00323.773.00False
2030-01-3156.90-11.010.0011.470.4640.00327.603.00False
2030-02-2851.40-9.950.0010.360.4140.00331.053.00False
2030-03-3156.90-11.010.0011.470.4640.00334.883.00False
2030-04-3055.07-10.660.0011.100.4440.00338.583.00False
2030-05-3156.90-11.010.0011.470.4640.00342.403.00False
2030-06-3055.07-10.660.0011.100.4440.00346.103.00False
2030-07-3156.90-11.010.0011.470.4640.00349.933.00False
2030-08-3156.90-11.010.0011.470.4640.00353.753.00False
2030-09-1527.53-5.33232.00247.229.8940.00436.163.00False
2030-09-3027.53-4.990.005.200.2140.00437.893.00False
2030-10-3156.90-10.310.0010.740.4340.00441.473.00False
2030-11-3055.07-9.980.0010.400.4240.00444.943.00False
2030-12-3156.90-10.310.0010.740.4340.00448.523.00False
2031-12-311,060.00-66.650.0069.432.7840.00471.663.00False
2032-12-311,500.0017.350.000.000.0040.00471.66—False
2033-12-311,920.00117.880.000.000.0040.00471.66—False
2034-12-312,260.00211.540.000.000.0040.00471.66—False
2035-12-312,570.00294.600.000.000.0040.00471.66—False
2036-12-312,800.00370.950.000.000.0040.00471.66—False
Capital and terminal bridge
{
  "equity_bridge": {
    "opening_cash_estimate": 398.00654945054936,
    "net_debt_subtracted_again": false,
    "initial_shares": 225.38901900000002,
    "final_shares": 471.66022404142683,
    "cumulative_equity_raise": 555.8136151242803,
    "warrant_cash": 183,
    "failure_recovery": null
  },
  "terminal_or_finite_life": {
    "growth": 0.025,
    "ROIC": 0.18,
    "terminal_equity_value_before_minority_bound": 2720.96264367816,
    "terminal_pv_per_share": 1.126020005056431,
    "terminal_fraction": 0.6892589115045094,
    "terminal_FCFE": 394.53958333333327,
    "terminal_reinvestment": 63.635416666666664
  }
}

What changes the answer

Operating sensitivity

2036 revenue scale (ramp gradually from fixed2027) × product gross-margin percentage points · present fair value per share

2036 revenue scaleGross margin changeValue / share
0.75×-5 pp$0.05
0.75×+0 pp$0.11
0.75×+5 pp$0.17
1.00×-5 pp$0.12
1.00×+0 pp$0.21
1.00×+5 pp$0.31
1.50×-5 pp$0.25
1.50×+0 pp$0.39
1.50×+5 pp$0.54
2.00×-5 pp$0.38
2.00×+0 pp$0.57
2.00×+5 pp$0.78

Funding and other sensitivities

Present fair value per share; one assumption changed at a time.

AssumptionBaseBull
no minority bound$0.22$1.71
starting trade wc zero$0.20$1.62
starting trade wc 20m$0.21$1.65
new forecast NOL 80pct offset$0.23$1.71
half issue price$0.12$1.17
double issue price$0.32$2.03
no warrant exercise$0.21$1.62
cost of equity 15pct$0.27$2.15
cost of equity 20pct$0.14$1.13
opening cash plus 20m$0.21$1.66
opening cash minus 20m$0.20$1.61

What the market price implies

Reverse expectations · not a forecast
$3,977m

2036 non-phone revenue required by the model to reconcile the dated $1.60 common quote, versus $810m in the base model. Mathematical solution; not demonstrated by disclosed orders or qualified capacity. No claim of physical impossibility.

Solved driver: 2036 non-phone sales scale, with linked interim cost/capital rules. Fixed assumptions: 2027 guide-midpoint start; base product margins; 8% incremental opex / 6% incremental capex / proportional WC; base debt, funding, tax, required return; no smartphone revenue/no warrant exercise.

Independent cross-check

independent competitor operating/capital evidence, not target averaging. A competitor with higher sales and lower capex does not justify capitalizing Enovix revenue at its multiple.

Amprius Q3 revenue $39.1m, GAAP gross margin 27%; its manufacturing model and capital requirements differ. These figures test the operating assumptions and are not a valuation multiple.

Return horizon & checkpoints

Revalue remaining 2031–2036 distributions and terminal at horizon using projected shares. Not a chosen target obtained by multiplying today's estimate. With no earlier payout, present/horizon values naturally reconcile at the same discount rate. Horizon: 2030-12-31. Subjective weighted future price $0.82; total return of expected cash flows -48.6%.

Scroll the table horizontally to view all columns on narrow screens.

Scenario2030 price / shareDistributions / shareTotal returnAnnualized IRR
Bear$0.00$0.00-100.0%Undefined: zero recovery
Base$0.40$0.00-75.2%-28.7%
Bull$3.13$0.0095.3%17.6%

IRR of subjective expected cash flows: -14.9%. Not computed: failure has zero recovery and no finite IRR. IRR of expected cash flows is a different quantity from a weighted mean of case IRRs.

Terminal reinvestment and capital bridge

Scenario-derived terminal capital arithmetic; not company guidance.

Mature-state bridge · $m unless %BaseBull
next year NOPAT109.66458.17
growth2.5%2.5%
ROIC16.0%18.0%
total growth reinvestment17.1363.64
next year DA45.10194.75
incremental trade working capital3.4411.20
incremental required cash1.001.00
implied gross capex57.79246.19
last explicit year gross capex61.00230.00
FCFE before minority92.53394.54
FCFE after minority bound88.64377.97

Gross capex = D&A + total growth reinvestment − Δtrade working capital − Δrequired operating cash. Terminal FCFE = NOPAT − total growth reinvestment.

Mature-state capital reconciliation; terminal growth slows to 2.5%. Minimum operating liquidity is productive operating capital, not separately added excess cash.

Methods, assumptions & sources

All model assumptions and conventions
  1. Valuation date November 13, 2026 after regular-session close; USD millions and million shares except per-share prices. Price $1.60 at 4:00 p.m. America/New_York (EST), verified by Stock Analysis historical row and Investing.com. It is ex-warrant common; Nasdaq says ex/record November 13 and no exchange-administered price adjustment. No warrant value is subtracted again and this buyer receives no separate warrant distribution.
  2. Operating forecast periods are calendar approximations of issuer fiscal years (differences up to several days), not quoted fiscal guidance. 2027 starts at $75m/$85m base/bull, within management FY2027 $65–85m guide; bear $60m misses it. Revenue is modeled evenly within each calendar year; actual shipments are lumpy. Q4 stub uses the $9.5m midpoint over 91 fiscal-quarter days through January 3, 2027.
  3. We do not pretend the company has disclosed segment revenue, ASPs, accepted-unit capacity or forecast margins. Korean, eyewear and phone revenue allocations are analyst assumptions. The base requires Korea $72m→$465m and eyewear $3m→$345m in 2027–2036; phones contribute zero. This is still rapid growth, not a flat-current-loss model. The bull requires phone requalification and $1.45bn phone sales by 2036, plus $700m Korea/$650m eyewear; this is an explicitly conditional upside, not an order book.
  4. Product gross margins in the forecast are economic margins before stock compensation allocated centrally to operating costs, not forecasts of reported GAAP gross margin. Base Korea matures at 35%, eyewear 42%; bull Korea 38%, eyewear 45%, phones 35%. Historical GAAP and adjusted margins remain labeled separately.
  5. Base economic operating expense falls $140m in 2027 to $110m in 2029, then rises to $165m by 2036. This assumes substantial additional portfolio prioritization and cost reduction if phones do not requalify. It is more than the disclosed $8.5m gross annual restructuring saving and is NOT management guidance. It gives management credit for adapting, rather than retaining phone-development costs forever without phone revenue. Bull expenses grow $142m→$470m to support the successful platform.
  6. Economic operating costs exclude amortization of already-granted awards, whose claim is recognized in starting shares. They include a separately assumed cost for NEW employee grants/replacement compensation: $12m, $16m, $25m in 2027–2029; thereafter 4% of revenue (base minimum $25m; bull minimum $30m), included within total operating expenses, not added again. No future grant dilution is layered on that expense. Depreciation is in operating costs/gross profit and added back once; cash capex and working capital are separately deducted.
  7. Beginning liquidity is an estimate, not a reported November balance: $512.159m Oct4 headline less $2.103m restricted, $81.4m approximate note-purchase cash, $15.5m October buybacks, $14.549m proxy burn (40 days × Q3 $33.1m/91) and $0.6m assumed additional accrued-interest/transaction adjustment = $398.007m. The proxy is only for the elapsed period; future burn is deducted once. Unknown actual movements are tested with ±$20m.
  8. FCFE is EBIT minus cash interest plus interest income minus cash taxes plus depreciation minus capex minus operating working capital minus debt principal. Cash/funding ledger begins with estimated liquidity; debt coupons and repayments are in it. Do NOT add cash or subtract net debt a second time from the resulting equity present value. $172.5m 2028 notes mature May1, $232m 2030 notes mature Sep15. Other loans approximately $11.8m are conservatively repaid June2027; short-loan interest proxy 5.2%. Operating lease costs remain in operating expense; lease debt is not separately deducted except in liquidation recovery.
  9. Cash settlement at face and no note-to-stock conversion is assumed in these paths; historical conversion references are far above modeled common-stock outcomes but current exact adjusted conversion rates are not asserted. Unexpected in-the-money conversion could change settlement economics and requires a new model. Cash coupons 3% and 4.75% are included. Surviving cases do not assume debt refinancing or future discounted repurchases.
  10. A permanent $40m operating liquidity buffer is held. It is required operating capital, not excess cash to add to equity; terminal reinvestment/ROIC includes its required growth. Cash in excess is notionally distributed after debt maturity from end2030. These are valuation cash distributions, not an announced dividend or capital-return policy. Estimated cash earns 2.5% while held.
  11. Funding is a conditional scenario assumption, not guaranteed execution: the base raises shares at $1.00 gross per share; bull at $3.00; 4% fees reduce usable cash. Versus $1.60 now these represent a down-round and a successful rerating, respectively. Continuous monthly draws summarize timing of required capital, not a forecast of dozens of actual offerings. Base new buyers may overpay relative to that ultimately realized case; market expectations can differ from outcomes. No perfect foresight financing is assumed. Funding unavailable is explicitly the bear failure case; issue prices and availability are leading risks.
  12. New financing shares = gross proceeds / assumed issue price; only net proceeds enter cash. Today's common receives future distributable cash divided by the actual future share count. This recognizes new investor ownership and never adds future proceeds as free value to existing owners. The unusually large cumulative raise is a warning, not a claim the financing market will supply it.
  13. Starting ownership uses Nov6 212.206365m shares, plus Oct4 10.155008m unvested RSUs, 1.942943m PRSUs and 1.084703m options, all as a deliberately conservative full-vesting/dilution bound with no option-exercise proceeds. This may overcount awards vested since Oct4 and ignores forfeitures; exact Nov13 award counts are unavailable. Options have $9.81 weighted-average strike, not a single common strike. Historical share repurchases are already in Nov6 shares and are not subtracted again. Removing the entire 13.183m award/option bound modestly increases value; it is not the driver of the call.
  14. Base assumes the approximately 61m new warrants expire unexercised; bull assumes full CASH exercise at $3 on Apr28 2028, conditional on a $3.53 contemporaneous market-price scenario (not a target or issuer projection), even though this realized scenario has lower conditional intrinsic value at that date. That adds $183m and 61m shares. No debt is removed on the same exercise. No-warrant exercise sensitivity is provided. The Apr28 timing also assumes no earlier acceleration: $3.30 VWAP on20 of30 trading days can trigger early expiry. A single assumed quote is not an assumed trigger history. Final warrant issuance and participation remain unknown; the 61m is the Nov13 issuer estimate, replacing older inconsistent FAQ arithmetic. Holders may instead tender eligible 2028 notes; that alternative requires debt reduction without cash and is not double-credited here.
  15. Bear misses the guide, assumes no new financing at the first modeled minimum-liquidity breach on May1 2028 (not a prediction of a legal insolvency date), and stops operations/model continuation. Recovery uses remaining cash, 30% of book PP&E and 50% of operating working capital, then all unpaid debt including the May1 maturity, $9.16m lease claim and $25m wind-down costs. Those are recovery assumptions, not appraisals. Senior claims exceed recovery assets, leaving zero common recovery. A zero conditional failure endpoint is not proof the business/stock has zero value today.
  16. Required equity return is a subjective 17%, with 15–20% sensitivity. This is FCFE, not WACC. It reflects time value/systematic uncertainty; commercial success/failure is in explicit cases, not an added generic probability haircut. Scenario weights 30% failure / 50% non-phone commercialization / 20% broad platform success are judgmental, not statistically calibrated. They give the nearer commercial path the largest weight, substantial financing-failure risk, and meaningful but smaller phone upside.
  17. Terminal growth 2.5% with 16% base/18% bull return on incremental operating capital. Debt-free terminal FCFE = next-year after-tax operating profit × (1−g/ROIC). Terminal reinvestment includes replacement/working capital/required operating cash; final-year D&A is not a perpetually free add-back. Terminal growth slows from the explicit final-year growth rate; margin stays at the final-year level. The terminal capex bridge is disclosed. A large terminal share means considerable model dependence.
  18. Taxes use a full 25% on positive pretax income and zero cash tax on losses, without assigning value to unverified legacy OR new loss attributes. This is a conservative tax convention, not a jurisdiction-specific tax forecast. A sensitivity allowing 80% offset from new forecast losses is shown; the base changes only modestly. No deferred tax asset is separately added.
  19. Reverse case scales the non-phone revenue path gradually from unchanged 2027 to a solved 2036 endpoint; adds 8% marginal operating cost, 6% incremental productive capex, and proportional working capital. Other margins, debt, funding price, tax and discount assumptions stay fixed. This is a single driver test with linked cost rules, not free revenue. Mathematical solution is not proof of feasible capacity or management guidance. Disclosed qualified units/ASPs are insufficient to validate the required output.
  20. Independent Amprius check: $39.1m Q3 sales, 27% GAAP gross margin; FY2026 guidance $145m sales, at least28% gross margin and capex below$10m; adjusted EBITDA guidance at least$2.5m includes an assumed$8m grant, which is not revenue. Its fabless partner access above2GWh is not owned dedicated output. Do not copy the margin, asset turnover, grant-supported EBITDA or market multiple into Enovix. It supports commercial demand but challenges Enovix's larger fixed-cost/capital burden. Neither company publishes enough matched ASP/yield data to claim a precise unit-cost comparison.
  21. The Oct4 narrowly defined trade working-capital proxy is $10.538m = AR4.277 + inventory19.849 − AP12.630 − current deferred revenue0.958. It is not current full operating working capital. Other current operating assets/liabilities are assumed to offset/remain unchanged. Forward trade WC of17% base/16% bull revenue is an analyst assumption, and starting-proxy0/$20m sensitivity is supplied.
  22. Routejade was95.8% owned at its2023 purchase; further minority shares were bought for$0.740m in2026, but current percentage is undisclosed. NCI book equity was$2.074m Oct4, not market value. To avoid allocating all consolidated cash to common, this model withholds a conservative4.2% of positive consolidated distributions and terminal equity for minority interests. This applies the old minority fraction to MORE than the subsidiary and may overstate the claim; it is an explicit valuation bound, not actual ownership. No-NCI-bound sensitivity raises base fromabout$0.21 to$0.22 and bull fromabout$1.63 to$1.71; the call is unchanged. No separate NCI book-value subtraction is added.
  23. Dated Street comparison: Stock Analysis/S&P Global Nov13 average12-month target$6.81 (12 analysts; median$5.25; range$2–15) contains differently aged estimates. Fresh Nov13 B.Riley and Craig-Hallum cut to$2 from$9/$7 and moved toHold/Neutral; Oppenheimer moved toPerform with no target displayed. These are analyst 12-month targets, NOT present fair value. We do not compare a present-value discount to a future target as if horizons matched.
Equations and claim treatment

FCFE = EBIT − cash interest + interest income − cash taxes + depreciation − capex − change in operating working capital − debt principal.

New financing shares = gross equity proceeds ÷ assumed issue price. Only net proceeds enter the cash ledger; future distributions are allocated across the then-outstanding shares. The estimated cash and debt are not added or subtracted again from FCFE present value.

Existing-award amortization excluded; new grant cost already in opex. No extra generic SBC deduction.

Evidence inputs and qualifications
InputValueAs ofCaveat
issued outstanding common212206365 shares2026-11-06November 6 not record-date final count; October buybacks are already reflected in this count.
quarter end cash equivalents63.225 USD millions2026-10-04
quarter end short term investments342.273 USD millions2026-10-04
quarter end long term investments104.558 USD millions2026-10-04
quarter end 2028 notes face172.5 USD millions2026-10-04Not confirmed November 13 outstanding balance.
quarter end 2030 notes face360 USD millions2026-10-04Predates October/November repurchases.
2030 notes repurchase face128 USD millions2026-11-13 filingAggregate Oct-Nov repurchases.
2030 notes repurchase cash81.4 USD millions2026-11-13 filingApproximate principal purchase cash, plus accrued interest.
2030 remaining face232 USD millions2026-11-13 filingReported after disclosed repurchases; not market value.
postquarter october stock repurchase cash15.5 USD millions2026-11-13 filingOctober buyback is reflected in November 6 outstanding count; no repurchase share count stated here.
short term debt11.7 USD millions2026-10-04Includes $0.2m current portion of long-term loans; approximate.
total long term loans0.3 USD millions2026-10-04Includes $0.2m current portion already in short-term debt; do not add both gross.
operating lease liabilities present value9.16 USD millions2026-10-04Keep valuation cash-flow and debt treatment consistent.
2028 notes fair value154.5 USD millions2026-10-04Historical issuer estimate, not current quote.
2030 notes fair value190.2 USD millions2026-10-04Before subsequent repurchases; not current quote.
expected 2026 warrants61.0 million warrants2026-11-13 filingIssuer estimate; final distribution unknown. Older Oct 28 FAQ estimates 65.6m.
stock options exercisable1084703 options2026-10-04Weighted average strike $9.81; distribution of strike prices varies.
restricted stock units unvested10155008 RSUs2026-10-04
performance stock units unvested1942943 PRSUs2026-10-04Subject to performance and forfeiture.
unrecognized equity compensation70.8 USD millions2026-10-04Expected weighted average recognition 2.9 years; includes already-granted awards; avoid double counting.
private placement warrants0 warrants2026-10-045.5m expired unexercised July 14; do not confuse with 2026 dividend warrants.
Source links

Quote is a dated historical close, not a live quote. Its source reference and distribution-basis documentation are retained with the model.